When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the'infodemic'surrounding COVID-19 DA Erku, SA Belachew, S Abrha, M Sinnollareddy, J Thomas, ... Research in Social and Administrative Pharmacy 17 (1), 1954-1963, 2021 | 311 | 2021 |
Inappropriate prescribing in chronic kidney disease: a systematic review of prevalence, associated clinical outcomes and impact of interventions WH Tesfaye, RL Castelino, BC Wimmer, STR Zaidi International journal of clinical practice 71 (7), e12960, 2017 | 112 | 2017 |
Evaluation of the diuretic activity of the aqueous and 80% methanol extracts of Ajuga remota Benth (Lamiaceae) leaves in mice W Hailu, E Engidawork BMC complementary and alternative medicine 14, 1-8, 2014 | 90 | 2014 |
Risk factors for COVID-19 infection, disease severity and related deaths in Africa: a systematic review HA Gesesew, DN Koye, DM Fetene, M Woldegiorgis, Y Kinfu, AB Geleto, ... BMJ open 11 (2), e044618, 2021 | 84 | 2021 |
Self-reported adverse drug reactions and their influence on highly active antiretroviral therapy in HIV infected patients: a cross sectional study WT Tadesse, AB Mekonnen, WH Tesfaye, YT Tadesse BMC pharmacology and Toxicology 15, 1-9, 2014 | 78 | 2014 |
Medication adherence, burden and health-related quality of life in adults with predialysis chronic kidney disease: a prospective cohort study WH Tesfaye, C McKercher, GM Peterson, RL Castelino, M Jose, ... International journal of environmental research and public health 17 (1), 371, 2020 | 70 | 2020 |
Assessment of drug use practices and completeness of prescriptions in Gondar University Teaching Referral Hospital E Admassie, B Begashaw, W Hailu International journal of pharmaceutical sciences and research 4 (1), 265, 2013 | 55 | 2013 |
Mānuka oil—A review of antimicrobial and other medicinal properties C Mathew, W Tesfaye, P Rasmussen, GM Peterson, A Bartholomaeus, ... Pharmaceuticals 13 (11), 343, 2020 | 47 | 2020 |
Medication non-adherence in chronic kidney disease: a mixed-methods review and synthesis using the theoretical domains framework and the behavioural change wheel WH Tesfaye, D Erku, A Mekonnen, YG Tefera, R Castelino, K Sud, ... Journal of nephrology, 1-35, 2021 | 44 | 2021 |
Efficacy and safety of tirzepatide in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized phase II/III trials AS Bhagavathula, K Vidyasagar, W Tesfaye Pharmaceuticals 14 (10), 991, 2021 | 41 | 2021 |
Extent of poly-pharmacy, occurrence and associated factors of drug-drug interaction and potential adverse drug reactions in Gondar Teaching Referral Hospital, North West Ethiopia E Admassie, T Melese, W Mequanent, W Hailu, BA Srikanth Journal of advanced pharmaceutical technology & research 4 (4), 183-189, 2013 | 36 | 2013 |
Medication regimen complexity and hospital readmission in older adults with chronic kidney disease WH Tesfaye, GM Peterson, RL Castelino, C McKercher, MD Jose, ... Annals of Pharmacotherapy 53 (1), 28-34, 2019 | 32 | 2019 |
How do we combat bogus medicines in the age of the COVID-19 pandemic? W Tesfaye, S Abrha, M Sinnollareddy, B Arnold, A Brown, C Matthew, ... The American Journal of Tropical Medicine and Hygiene 103 (4), 1360, 2020 | 30 | 2020 |
Psychosocial factors affecting patients with end-stage kidney disease and the impact of the social worker MS Hansen, W Tesfaye, B Sewlal, B Mehta, K Sud, L Kairaitis, S Tarafdar, ... Journal of nephrology, 1-16, 2022 | 28 | 2022 |
In vivo antimalarial activity of the crude extract and solvent fractions of the leaves of Zehenria scabra (Cucurbitaceae) against Plasmodium berghei in mice WH Tesfaye, EA Alamneh J Med Plant Res 8 (42), 1230-1236, 2014 | 27 | 2014 |
Emerging treatment strategies for impetigo in endemic and nonendemic settings: a systematic review G Gahlawat, W Tesfaye, M Bushell, S Abrha, GM Peterson, C Mathew, ... Clinical therapeutics 43 (6), 986-1006, 2021 | 25 | 2021 |
Intolerable burden of impetigo in endemic settings: a review of the current state of play and future directions for alternative treatments S Abrha, W Tesfaye, J Thomas Antibiotics 9 (12), 909, 2020 | 20 | 2020 |
Strategies to increase the pharmacist workforce in rural and remote Australia: a scoping review KO Obamiro, W Tesfaye, T Barnett Rural and remote health 20 (4), 1-8, 2020 | 20 | 2020 |
Polypharmacy and hyperpolypharmacy in older individuals with Parkinson’s disease: a systematic review and meta-analysis AS Bhagavathula, W Tesfaye, K Vidyasagar, D Fialova Gerontology 68 (10), 1081-1090, 2022 | 18 | 2022 |
The effect of hospitalization on potentially inappropriate medication use in older adults with chronic kidney disease W Tesfaye, B Wimmer, R Castelino, GM Peterson, M Jose, C McKercher, ... European Geriatric Medicine 9 (Supplement 1), S45, 2018 | 18 | 2018 |